Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/CMAR.S244748 http://scihub22266oqcxt.onion/10.2147/CMAR.S244748 32617021!7326172!32617021     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32617021&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cancer+Manag+Res 2020 ; 12 (?): 5131-5139 Nephropedia Template TP {{tp|p=32617021|t=2020. Anticancer Effects of ACT001 via NF-kappaB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1 |pdf=|usr=}}{{32617021}} gab.com Text Anticancer Effects of ACT001 via NF-kappaB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1 JO: Cancer Manag Res http://www.kidney.de/pget.php?&tw=1&pmid=32617021 #FOAvip PURPOSE: ACT001 is a novel sesquiterpene lactone derivative with anticancer effects, including the reversal of tamoxifen resistance in estrogen receptor-positive breast cancer cells. However, few studies have investigated the anticancer effects of ACT001 in triple-negative breast cancer (TNBC), a highly aggressive cancer with a poor prognosis. This study aimed to investigate the effects of ACT001 on TNBC and the potential mechanism underlying these effects. MATERIALS AND METHODS: The anticancer effects of ACT001 on the murine TNBC cell line 4T1 were evaluated by Cell Counting Kit-8 assay, animal experiments, TUNEL staining, flow cytometry, immunofluorescence, enzyme-linked immunosorbent assay, and Western blotting analysis. RESULTS: ACT001 induced apoptosis in 4T1 cells by upregulating B cell lymphoma 2-associated X protein expression. Moreover, ACT001 markedly decreased levels of secretory granulocyte-macrophage colony stimulating factor (GM-CSF) in 4T1 tumors, decreased the number of myeloid-derived suppressor cells (MDSCs), and reduced angiogenesis. Furthermore, GM-CSF promoted angiogenesis and the proliferation of MDSCs in a dose-dependent manner. Finally, ACT001 suppressed phospho-NF-kappaB and IkappaB-alpha levels in 4T1 cells, thereby further decreasing GM-CSF levels. CONCLUSION: Our results suggest that ACT001 exerts its anticancer effects by inducing apoptosis in murine TNBC cell line 4T1 and regulates the tumor microenvironment by attenuating angiogenesis and accumulation of MDSCs in 4T1 tumors. The underlying mechanism may involve the suppression of NF-kappaB activity. Twit Text FOAVip Anticancer Effects of ACT001 via NF-kappaB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1 ????Cancer Manag Res http://www.kidney.de/pget.php?&tw=1&pmid=32617021 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32617021 #FOAvip English Wikipedia <ref>{{Cite pmid|32617021}}</ref> Anticancer Effects of ACT001 via NF-kappaB Suppression in Murine Triple-Negative Breast Cancer Cell Line 4T1 #MMPMID32617021 Liu Y; Wang L; Liu J; Xie X; Hu H; Luo F Cancer Manag Res 2020[]; 12 (?): 5131-5139 PMID32617021show ga PURPOSE: ACT001 is a novel sesquiterpene lactone derivative with anticancer effects, including the reversal of tamoxifen resistance in estrogen receptor-positive breast cancer cells. However, few studies have investigated the anticancer effects of ACT001 in triple-negative breast cancer (TNBC), a highly aggressive cancer with a poor prognosis. This study aimed to investigate the effects of ACT001 on TNBC and the potential mechanism underlying these effects. MATERIALS AND METHODS: The anticancer effects of ACT001 on the murine TNBC cell line 4T1 were evaluated by Cell Counting Kit-8 assay, animal experiments, TUNEL staining, flow cytometry, immunofluorescence, enzyme-linked immunosorbent assay, and Western blotting analysis. RESULTS: ACT001 induced apoptosis in 4T1 cells by upregulating B cell lymphoma 2-associated X protein expression. Moreover, ACT001 markedly decreased levels of secretory granulocyte-macrophage colony stimulating factor (GM-CSF) in 4T1 tumors, decreased the number of myeloid-derived suppressor cells (MDSCs), and reduced angiogenesis. Furthermore, GM-CSF promoted angiogenesis and the proliferation of MDSCs in a dose-dependent manner. Finally, ACT001 suppressed phospho-NF-kappaB and IkappaB-alpha levels in 4T1 cells, thereby further decreasing GM-CSF levels. CONCLUSION: Our results suggest that ACT001 exerts its anticancer effects by inducing apoptosis in murine TNBC cell line 4T1 and regulates the tumor microenvironment by attenuating angiogenesis and accumulation of MDSCs in 4T1 tumors. The underlying mechanism may involve the suppression of NF-kappaB activity. ?Anticancer Effects of ACT001 via NF-kappaB Suppression in Murine Tripl(epmc).pdf DeepDyve Pubget Overpricing